Priti Kadu

Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs.

Guixia Wang, C. Ersoy, Wenying Yang, 2019, Diabetes research and clinical practice.

Safety and Efficacy of Subcutaneous (SC) Blinatumomab for the Treatment of Adults with Relapsed or Refractory B Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)

B. Panwar, J. Hernández-Rivas, G. Rossi, 2021, Blood.

A Phase 1b Study of Blinatumomab Including Subcutaneous Administration in Relapsed / Refractory (R/R) Indolent Non Hodgkin's Lymphoma (NHL)

S. Ferrari, C. Haioun, C. Tam, 2021, Blood.